Setiptiline

Setiptiline
Clinical data
Trade names	Tecipul
Other names	Teciptiline; delta(13b,4a),4a-Carba-mianserin; MO-8282; ORG-8282
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 2-methyl-2,3,4,9-tetrahydro-1H-dibenzo[3,4:6,7]cyclohepta[1,2-c]pyridine;
CAS Number	57262-94-9 ;
PubChem CID	5205;
DrugBank	DB09304 ;
ChemSpider	5016 ;
UNII	7L38105Z6E;
KEGG	D08511 ;
ChEBI	CHEBI:135076;
CompTox Dashboard (EPA)	DTXSID50205886 ;
ECHA InfoCard	100.055.123
Chemical and physical data
Formula	C19H19N
Molar mass	261.368 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES c42c(\C3=C(/c1ccccc1C2)CN(C)CC3)cccc4;
	InChI InChI=1S/C19H19N/c1-20-11-10-18-16-8-4-2-6-14(16)12-15-7-3-5-9-17(15)19(18)13-20/h2-9H,10-13H2,1H3 ; Key:GVPIXRLYKVFFMK-UHFFFAOYSA-N ;
	(what is this?) (verify)

Setiptiline (brand name Tecipul), also known as teciptiline, is a tetracyclic antidepressant (TeCA) that acts as a noradrenergic and specific serotonergic antidepressant (NaSSA). It was launched in 1989 for the treatment of depression in Japan by Mochida.